No Data
No Data
No Data
No Data
No Data
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
DURHAM, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients
ChimerixApr 24 12:00
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DURHAM, N.C., April 16, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX) today announced that on April 10, 2024, the Compensation Committee of Chimerix's Board of Directors granted inducement awards
ChimerixApr 16 12:00
We Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully
Yahoo FinanceApr 15 18:17
Chimerix Board Changes: Machado Resigns, Kozin Appointed
TipRanksMar 21 20:42
Analysts Offer Insights on Healthcare Companies: Chimerix (CMRX), DENTSPLY SIRONA (XRAY) and Karuna Therapeutics (KRTX)
TipRanksMar 5 14:31
HC Wainwright & Co. Reiterates Buy on Chimerix, Maintains $11 Price Target
HC Wainwright & Co. analyst Edward White reiterates Chimerix (NASDAQ:CMRX) with a Buy and maintains $11 price target.
BenzingaMar 1 20:14
No Data
No Data